Literature DB >> 101276

In-vitro antimicrobial susceptibility of Neisseria gonorrhoeae in New Zealand.

M J Green.   

Abstract

Four hundred and forty-two isolates of Neisseria gonorrhoeae were tested by an agar dilution method for their susceptibility to penicillin, ampicillin, tetracycline, cephaloridine, and spectinomycin. Of these isolates, 295 were tested for their susceptibility to sulphamethoxazole and to trimethoprim by the same method, using Oxoid diagnostic sensitivity test agar plus 7.5% laked horse blood instead of Proteose No. 3 agar plus 1% IsoVitaleX and 1% haemoglobin. One hundred (22.6%) of the isolates were found to be relatively resistant to penicillin (minimum inhibitory concentration (MIC) less than 0.1 iu/ml), but only 1.1% had a MIC of 1 iu/ml or higher. Ampicillin was slightly more active than penicillin in that all isolates were inhibited by 0.5 microgram/ml or less. For 3.7% of isolates the MIC of tetracycline was 2 microgram/ml or higher. All isolates were sensitive to spectinomycin. By calculating the Spearman rank correlation coefficient (rs), a high correlation (rs greater than 0.5) was found between susceptibility to penicillin and susceptibility to ampicillin, tetracycline, and cephaloridine. Low correlation (rs less than 0.2) was found between susceptibility to penicillin and susceptibility to spectinomycin, sulphamethoxazole, and trimethoprim.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 101276      PMCID: PMC1045530          DOI: 10.1136/sti.54.5.316

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  13 in total

Review 1.  Antibiotic resistance in Neisseria gonorrhoeae.

Authors:  P F Sparling
Journal:  Med Clin North Am       Date:  1972-09       Impact factor: 5.456

2.  In-vitro activity of twelve antibacterial agents against Neisseria gonorrhoeae.

Authors:  I Phillips; M Ridley; D Rimmer; R Lynn
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

3.  Minimum inhibitory concentrations of penicillin and minocycline for 300 isolates of N. gonorrhoeae.

Authors:  M Shahidullah; P W Greaves
Journal:  Br J Vener Dis       Date:  1975-08

4.  Resistance of Neisseria gonorrhoeae to penicillin in 199 gonococcal infections in women and the response of those infections to penicillin treatment.

Authors:  B A Smithurst
Journal:  Med J Aust       Date:  1974-04-13       Impact factor: 7.738

5.  Activity of eight antimicrobial agents in vitro against N. Gonorrhoeae.

Authors:  E Stolz; H G Zwart; M F Michel
Journal:  Br J Vener Dis       Date:  1975-08

6.  Antibiotic sensitivity of gonococci in South Australia, 1974 to 1975.

Authors:  A Finger; G Handke
Journal:  Med J Aust       Date:  1977-01-29       Impact factor: 7.738

7.  Susceptibility of Neisseria gonorrhoeae to seven antibiotics in vitro.

Authors:  H G Robson; I E Salit
Journal:  Can Med Assoc J       Date:  1972-11-18       Impact factor: 8.262

8.  Antibiotic sensitivities of Neisseria gonorrhoeae in the Toronto area.

Authors:  K F Givan; A Keyl
Journal:  Can Med Assoc J       Date:  1974-07-06       Impact factor: 8.262

9.  Activity in vitro of ten antimicrobial agents against Neisseria gonorrhoeae. A study of the correlation between the sensitivities.

Authors:  A Meheus; P Piot; S Pattyn; E van Dyck; D van den Berghe
Journal:  Br J Vener Dis       Date:  1976-10

10.  Resistance of Neisseria gonorrhoeae to antibacterial drugs in Ontario.

Authors:  R Shtibel
Journal:  Health Lab Sci       Date:  1976-01
View more
  3 in total

1.  Susceptibility to antimicrobials of Neisseria gonorrhoeae isolated in Singapore: implications on the need for more effective treatment regimens and control strategies.

Authors:  E H Sng; A L Lim; K L Yeo
Journal:  Br J Vener Dis       Date:  1984-12

2.  Antibiotic susceptibilities, serotypes and auxotypes of Neisseria gonorrhoeae isolated in New Zealand.

Authors:  M S Brett; H G Davies; J R Blockley; H M Heffernan
Journal:  Genitourin Med       Date:  1992-10

3.  DNAJC12 as a Mediator Between ESR1 and ERBB4 in Breast Carcinoma Cells.

Authors:  Mianjie Lin; Ya-Nan Wang; Yixin Ye; Zhelei Xiong; Fengbiao Guo; Haibin Chen
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.